Madelé van Dyk

Plasma extracellular nanovesicle (exosome)‐derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposure

Andrew Rowland, Warit Ruanglertboon, Madelé van Dyk et al. · British Journal of Clinical Pharmacology · 2018 · 80 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Perspectives on Model‐Informed Precision Dosing in the Digital Health Era: Challenges, Opportunities, and Recommendations

Franziska Kluwe, Robin Michelet, Anna Mueller‐Schoell et al. · Clinical Pharmacology & Therapeutics · 2020 · 66 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Exploring the Use of Serum‐Derived Small Extracellular Vesicles as Liquid Biopsy to Study the Induction of Hepatic Cytochromes P450 and Organic Anion Transporting Polypeptides

A. David Rodrigues, Madelé van Dyk, Michael J. Sorich et al. · Clinical Pharmacology & Therapeutics · 2021 · 63 citations

Medicine, Biochemistry, Pharmacology +17

Physiologically Based Pharmacokinetic Modeling to Identify Physiological and Molecular Characteristics Driving Variability in Drug Exposure

Andrew Rowland, Madelé van Dyk, Ashley M. Hopkins et al. · Clinical Pharmacology & Therapeutics · 2018 · 35 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: A pilot study

E.D. Bateman, Madelé van Dyk, Alexandros Sagriotis · Pulmonary Pharmacology & Therapeutics · 2006 · 31 citations

Medicine, Clinical Sciences, Pharmacotherapy +14